Hypocalcemia is most commonly seen within the first six months of GLP-1 receptor agonist therapy, while hypercalcemia is noted to occur after at least six months of therapy
Maleki H, Shahbazi MA, Montes S, Hosseini SH, Eskandari MR, Zaunschirm S
The frequency of administration of a GLP-1 receptor agonist depends on its half-life
Cases of hypoglycemia have been reported very rarely in patients taking tramadol
This ensures they are not only effective but also safe for use under recommended conditions
We calculated Pearsons correlation coefficient to assess correlations between significant GPs (i.e., GPs that showed significant fold changes at the end of 4th week during 4-week intermittent fasting and 1 week after 4-week intermittent fasting) and the components of metabolic syndrome, lipid panel, hepatic panel, and adiposity, oxidative stress, and inflammation biomarkers